Compare Globalstar (GSAT) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globalstar vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Globalstar trades at $83.3 (market cap $10.78B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.79 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.3× Globalstar's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Globalstar pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 20 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| GSAT | RPRX | |
|---|---|---|
Market Cap | $10.78B | $25.27B |
Volume | 723,953 | 3,671,183 |
Sector | Media | Health |
52-Week High | $84.43 | $63.96 |
52-Week Low | $41.54 | $35.44 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $10.79B | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globalstar
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
